drugset
drugset / Trial / NCT04956263

A Comparison of Postprandial Glucose After a MMTT, and the Metabolic Effects of Insulin Withdrawal in a Crossover Study in Subjects With Type 1 Diabetes

NCT04956263 ↗

Phase 2 Completed 19 enrolled Youngene Therapeutics Inc., Ltd. ProSciento, Inc. · collab
RandomizedCrossoverQuadruple-blindTreatment

Summary

This is an inpatient treatment, double-blind, randomized, 3-way crossover study in T1DM subjects using insulin pump therapy.

Timeline

Start
2021-06-17
Primary completion
2022-02-02
Completion
2022-07-19

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dapagliflozin Small molecule 10 mg —
Subject YG1699 Small molecule 10 mg Oral
Subject YG1699 Small molecule 25 mg Oral

Indications

type 1 diabetes mellitus